This morning Bloomberg reported that Actavis (NYSE: ACT) balked at the price offered by Valeant (NYSE: VRX) in a deal ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE